Molecular approaches for classifying endometrial carcinoma

JM Piulats, E Guerra, M Gil-Martín, B Roman-Canal… - Gynecologic …, 2017 - Elsevier
Endometrial carcinoma is the most common cancer of the female genital tract. This review
article discusses the usefulness of molecular techniques to classify endometrial carcinoma …

High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations

R Murali, B Davidson, O Fadare… - International Journal …, 2019 - journals.lww.com
This review of challenging diagnostic issues concerning high-grade endometrial carcinomas
is derived from the authors' review of the literature followed by discussions at the …

Diagnostic algorithmic proposal based on comprehensive immunohistochemical evaluation of 297 invasive endocervical adenocarcinomas

S Stolnicu, I Barsan, L Hoang, P Patel… - The American journal …, 2018 - journals.lww.com
Abstract The International Endocervical Adenocarcinoma Criteria and Classification was
developed to separate endocervical adenocarcinomas (ECAs) into 2 main categories on the …

Pathology of endometrial carcinoma

SF Lax - Molecular Genetics of Endometrial Carcinoma, 2017 - Springer
On a clinicopathological and molecular level, two distinctive types of endometrial carcinoma,
type I and type II, can be distinguished. Endometrioid carcinoma, the typical type I …

Practical applications in immunohistochemistry: carcinomas of unknown primary site

PL Kandalaft, AM Gown - Archives of pathology & …, 2016 - meridian.allenpress.com
Context.—Identification of the site of origin of carcinoma of unknown primary using
immunohistochemistry is a frequent requirement of anatomic pathologists. Diagnostic …

Targeted mutation analysis of endometrial clear cell carcinoma

LN Hoang, MK McConechy, B Meng… - …, 2015 - Wiley Online Library
Aims Endometrial clear cell carcinomas (CCC) constitute fewer than 5% of all carcinomas of
the endometrium. Currently, little is known regarding the genetic basis of endometrial CCC …

[HTML][HTML] How to approach the many faces of endometrioid carcinoma

A Malpica - Modern Pathology, 2016 - Elsevier
This article reviews the salient features of variants of endometrioid carcinoma (ECa) that can
pose a diagnostic challenge and/or are associated with unique clinicopathological findings …

[HTML][HTML] Napsin A is a specific marker for ovarian clear cell adenocarcinoma

Y Yamashita, T Nagasaka, A Naiki-Ito, S Sato… - Modern Pathology, 2015 - Elsevier
Ovarian clear cell adenocarcinoma has a relatively poor prognosis among the ovarian
cancer subtypes because of its high chemoresistance. Differential diagnosis of clear cell …

Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma

D Lim, PPC Ip, ANY Cheung… - The American Journal …, 2015 - journals.lww.com
Accurate distinction of clear cell carcinoma (CCC) from endometrioid carcinoma (EC) has
important clinical implications, but, not infrequently, EC demonstrates clear cell change (EC …

Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian …

O Fadare, C Zhao, D Khabele, V Parkash, CM Quick… - Pathology, 2015 - Elsevier
Napsin A and α-methylacyl-coenzyme A racemase (AMACR, P504S) have recently been
described as being frequently expressed in clear cell carcinomas (CCC) of the …